Low-plasma insulin-like growth factor-I levels are associated with impaired endothelium-dependent vasodilatation in a cohort of untreated, hypertensive caucasian subjects

Journal of Clinical Endocrinology and Metabolism

Volumn 93, Issue 7, 2008, Pages 2806-2810

  Perticone, Francesco ^a,b   Sciacqua, Angela ^a   Perticone, Maria ^a   Laino, Irma ^a   Miceli, Sofia ^a   Caré, Ilaria ^a   Leone, Giulia Galiano ^a   Andreozzi, Francesco ^a   Maio, Raffaele ^a   Sesti, Giorgio ^a  

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^b Policlinico Mater Domini   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; HIGH DENSITY LIPOPROTEIN; NITROPRUSSIDE SODIUM; SOMATOMEDIN C;

ADULT; AGE; ARTICLE; CARDIOVASCULAR RISK; CAUCASIAN; DOSE RESPONSE; ENDOTHELIUM; EVALUATION; FEMALE; FOREARM BLOOD FLOW; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; INSULIN SENSITIVITY; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OUTPATIENT; PLETHYSMOGRAPHY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REGRESSION ANALYSIS; SYSTOLIC BLOOD PRESSURE; VASODILATATION;

EID: 47549093740     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2008-0646     Document Type: Article

References (35)

1. Conti E, Carrozza C, Capoluogo E, Volpe M, Crea F, Zuppi C, Andreotti F 2004 Insulin-like growth factor-1 as a vascular protective factor. Circulation 110:2260-2265
2. Sesti G, Sciacqua A, Scozzafava A, Vatrano M, Angotti E, Ruberto C, Santillo E, Parlato G, Perticone F 2007 Effects of growth hormone and insulin-like growth factor-1 on cardiac hypertrophy of hypertensive patients. J Hypertens 25:471-477
3. Spallarossa P, Brunelli C, Minuto F, Caruso D, Battistini M, Caponnetto S, Cordera R 1996 Insulin-like growth factor-1 and angiographically documented coronary artery disease. Am J Cardiol 77:200-202
4. Janssen J, Stolk RP, Pols H, Grobbee DE, Lamberts SW 1998 Serum total IGF-1, free IGF-1, and IGFBP-1 levels in an elderly population: relation to cardiovascular risk factors and disease. Arterioscler Thromb Vasc Biol [Erratum (1998) 18:1197]18:277-282
5. Van den Beld AW, Bots ML, Janssen JA, Pols HA, Lamberts SW, Grobbee DE 2003 Endogenous hormones and carotid atherosclerosis in elderly men. Am J Epidemiol 157:25-31
6. Juul A, Scheike T, Davidsen M, Gyllenborg J, Jørgensen T 2002 Low serum insulin-like growth factor 1 is associated with increased risk of ischemic heart disease: a population-based case-control study. Circulation 106:939-944
7. Laughlin GA, Barrett-Connor E, Criqui MH, Kritz-Silverstein D 2004 The prospective association of serum insulin-like growth factor I (IGF-I) and IGF-binding protein-1 levels with all cause and cardiovascular disease mortality in older adults: the Rancho Bernardo Study. J Clin Endocrinol Metab 89:114-120
8. Johnsen SP, Hundborg HH, Sorensen HT, Orskov H, Tjonneland A, Overvad K, Jorgensen JO 2005 Insulin-like growth factor (IGF) I, -II, and IGF binding protein-3 and risk of ischemic stroke. J Clin Endocrinol Metab 90:5937-5941
9. Kaplan RC, McGinn AP, Pollak MN, Kuller LH, Strickler HD, Rohan TE, Cappola AR, Xue XN, Psaty BM 2007 Association of total insulin-like growth factor-I, insulin-like growth factor binding protein-1 (IGFBP-1), and IGFBP-3 levels with incident coronary events and ischemic stroke. J Clin Endocrinol Metab 92:1319-1325
10. Conti E, Andreotti F, Sciahbasi A, Riccardi P, Marra G, Menini E, Ghirlanda G, Maseri A 2001 Markedly reduced insulin-like growth factor-1 in the acute phase of myocardial infarction. J Am Coll Cardiol 38:26-32
11. Colao A, Di Somma C, Filippella M, Rota F, Pivonello R, Orio F, Vitale G, Lombardi G 2004 Insulin-like growth factor-1 deficiency determines increased intima-media thickness at common carotid arteries in adult patients with growth hormone deficiency Clin Endocrinol (Oxf) 61:360-366
12. Rosen T, Bengtsson BA 1990 Premature mortality due to cardiovascular disease in hypopituitarism. Lancet 336:285-288
13. Bülow B, Hagmar L, Eskilsson J, Erfurth EM 2000 Hypopituitary females have a high incidence of cardiovascular morbidity and an increased prevalence of cardiovascular risk factors. J Clin Endocrinol Metab 85:574-584
14. Ross R 1993 The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362:801-809
15. Panza JA, Quyyumi AA, Brush JE, Epstein SE 1990 Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med 223:22-27
16. Perticone F, Ceravolo R, Pujia A, Ventura G, Iacopino S, Scozzafava A, Ferraro A, Chello M, Mastroroberto P, Verdecchia P, Schillaci G 2001 Prognostic significance of endothelium dysfunction in hypertensive patients. Circulation 104:191-196
17. Fryburg DA 1996 NG-monomethyl-L-arginine inhibits the blood flow but not the insulin-like response of forearm muscle to IGF- I: possible role of nitric oxide in muscle protein synthesis. J Clin Invest 97:1319-1328
18. Pendergrass M, Fazioni E, Collins D, DeFronzo RA 1998 IGF-1 increases forearm blood flow without increasing forearm glucose uptake. Am J Physiol 275(2 Pt 1):E345-E350
19. Chisalita SI, Arnqvist HJ 2004 Insulin-like growth factor 1 receptors are more abundant than insulin receptors in human micro- and macrovascular endothelial cells. Am J Physiol Endocrinol Metab 286:E896-E901
20. Tsukahara H, Gordienko DV, Tonshoff B, Gelato MC, Goligorsky MS 1992 Direct demonstration of insulin-like growth factor 1 induced nitric oxide production by endothelial cells. Kidney Int 45:598-604
21. Walsh F, Barazi M, Pete G, Muniyappa R, Dunbar JC, Sowers JR 1996 Insulin-like growth factor I diminishes in vivo and in vitro vascular contractility: role of vascular nitric oxide. Endocrinology 137:1798-1803
22. Tivesten Å, Bollanom E, Andersson I, Fitzgerald S, Caidahl K, Sjogren K, Skøtt O, Liu JL, Mobini R, Isaksson OG, Jansson JO, Ohlsson C, Bergstrom G, Isgaard J 2002 Liver-derived insulin-like growth factor-I is involved in the regulation of blood pressure in mice. Endocrinology 143:4235-4242
23. Scheidegger KJ, James RW, Delafontaine P 2000 Differential effects of low density lipoproteins on insulin-like growth factor-1 (IGF-1) and IGF-1 receptor expression in vascular smooth muscle cells. J Biol Chem 275:26864-26869
24. Sesti G, Sciacqua A, Cardellini M, Marini MA, Maio R, Vatrano M, Succurro E, Lauro R, Federici M, Perticone F 2005 Plasma concentration of insulin-like growth factor-1 is independently associated with insulin sensitivity in subjects with different degree of glucose tolerance. Diabetes Care 28:132-137
25. Gómez JM, Maravall FJ, Gómez N, Navarro MA, Casamitjana R, Soler J 2003 Interactions between serum leptin, the insulin-like growth factor-1 system, and sex, age, anthropometric and body composition variables in a healthy population randomly selected. Clin Endocrinol (Oxf) 58:213-219
26. Sandhu MS, Heald AH, Gibson JM, Cruickshank JK, Dunger DB, Wareham NJ 2002 Circulating concentrations of insulin-like growth factor-1 and development of glucose intolerance: a prospective observational study. Lancet 359:1740-1745
27. Teramukai S, Rohan T, Eguchi H, Oda T, Shinchi K, Kono S 2002 Anthropometric and behavioral correlates of insulin-like growth factor-1 and insulinlike growth factor binding protein 3 in middle-aged Japanese men. Am J Epidemiol 156:344-348
28. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, Grassi G, Heagerty AM, Kjeldsen SE, Laurent S, Narkiewicz K, Ruilope L, Rynkiewicz A, Schmieder RE, Boudier HA, Zanchetti A, Vahanian A, Camm J, De Caterina R, Dean V, Dickstein K, Filippatos G, Funck-Brentano C, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL, Erdine S, Kiowski W, Agabiti-Rosei E, Ambrosioni E, Lindholm LH, Viigimaa M, Adamopoulos S, Agabiti-Rosei E, Ambrosioni E, Bertomeu V, Clement D, Erdine S, Farsang C, Gaita D, Lip G, Mallion JM, Manolis AJ, Nilsson PM, O'Brien E, Ponikowski P, Redon J, Ruschitzka F, Tamargo J, van Zwieten P, Waeber B, Williams B, Management of Arterial Hypertension of the European Society of Hypertension, European Society of Cardiology 2007 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens [Erratum (2007) 25:1749] 25:1105-1187
29. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC 1985 Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419
30. Schult AF, Janssen JA, Deinum J, Vergeer JM, Hofman A, Lamberts SW, Oostra BA, Pols HA, Witteman JC, van Duijn CM 2003 Polymorphism in the promoter region of the insulin-like growth factor 1 gene is related to carotid intima-media thickness and aortic pulse wave velocity in subjects with hypertension. Stroke 34:1623-1627
31. Wickman A, Jonsdottir IH, Bergstrom G, Hedin L 2002 GH and IGF-1 regulate the expression of endothelial nitric oxide synthase (eNOS) in cardiovascular tissues of hypophysectomized female rats. Eur J Endocrinol 147:523-533
32. Bornfeldt KE, Arnqvist HJ, Dahlkvist HH, Skottner A, Wikberg JE 1988 Receptors for insulin-like growth factor-I in plasma membranes isolated from bovine mesenteric arteries. Acta Endocrinol (Copenh) 117:428-434
33. Okura Y, Brink M, Zahid AA, Anwar A, Delafontaine P 2001 Decreased expression of insulin-like growth factor-1 and apoptosis of vascular smooth muscle cells in human atherosclerotic plaque. J Mol Cell Cardiol 33:1777-1789
34. Patel VA, Zhang QJ, Siddle K, Soos MA, Goddard M, Weissberg PL, Bennett MR 2001 Defect in insulin-like growth factor-1 survival mechanism in atherosclerotic plaque-derived vascular smooth muscle cells is mediated by reduced surface binding and signaling. Circ Res 88:895-902
35. Reaven GM, Lithell H, Landsberg L 1996 Hypertension and associated metabolic abnormalities-the role of insulin resistance and the sympathoadrenal system. N Engl J Med 334:374-381